Biotech have taken the front seat in the mergers and acquisitions conversation already in 2015. Transactions in the sector have been impressive just 5 months into the calendar year, causing the NASDAQ iShares Biotechnology index to jump 19% and 59% over the last 12 months. Previously covered on Johnjellinek.com, there have been biotech skepticism surrounding […]